Ascendis Pharma A ASND
NASDAQ ASND
$242.99 +4.09 (+1.71%)
At close: Oct 22, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Total Debt (2021 - 2026)

Updated

Ascendis Pharma A's Total Debt was $447.09 million in the quarter ended Jun 30, 2026, down 57.7% from $1.06 billion a year earlier and down 66.0% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Total Debt (2021 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Debt at Ascendis Pharma A came in at $1.21 billion, up 14.8% from the prior year.

  • Total Debt has now increased for four consecutive years, with a four-year compound annual growth rate of 81.3% (years ended Dec 2021 to Dec 2025).
  • In earlier years, Total Debt was $1.05 billion in the year ended Dec 31, 2024 (+26.0%), $836.59 million in the year ended Dec 31, 2023 (+104.8%), $408.47 million in the year ended Dec 31, 2022 (+264.5%) and $112.07 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Debt since the quarter ended Dec 31, 2022.
  • Compared with a year earlier, Total Debt was higher in seven of the last eight quarters, with growth averaging 16.5%.
  • The best year-over-year quarter for Total Debt over five years was the quarter ended Dec 31, 2022 (growth of 252.8%); the worst was the quarter ended Jun 30, 2026 (a decline of 57.7%).
  • Per Business Quant data, ASND's Total Debt in the three quarters before the quarter ended Jun 30, 2026 was $1.32 billion (quarter ended Mar 31, 2026), $1.25 billion (quarter ended Dec 31, 2025) and $1.16 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Ascendis Pharma A 14.69 Bn 10.95 Bn 362.22 Mn 970.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 970.34 Mn
Mar 31, 2026 442.48 Mn
Dec 31, 2025 1.41 Bn
Sep 30, 2025 1.27 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.16 Bn
Dec 31, 2024 1.17 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 972.04 Mn
Mar 31, 2024 897.35 Mn
Dec 31, 2023 903.40 Mn
Sep 30, 2023 809.79 Mn
Jun 30, 2023 549.85 Mn
Mar 31, 2023 551.10 Mn
Dec 31, 2022 425.56 Mn
Sep 30, 2022 543.81 Mn
Jun 30, 2022 535.08 Mn
Mar 31, 2022 528.69 Mn
Dec 31, 2021 118.87 Mn
API Access

Ascendis Pharma A Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ASND&period=max&api_key=YOUR_API_KEY